ONCOSIL MEDICAL LIMITED ABN 89 113 824 141 ASX | OSL Level 5, 7 Eden Park Drive, Macquarie Park, NSW 2113 AUSTRALIA TELEPHONE +61 2 8935 9629 WEB www.oncosil.com 1 ASX Announcement 15 September 2026 Notice under ASX Listing Rule 3.10A Sydney, Australia – 15 September 2026: OncoSil Medical...
Notice under ASX Listing Rule 3.10A
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from OncoSil Medical
- Change in substantial holding
- Change in substantial shareholding for OSL
- Notice Under Section 708A
- Application for quotation of securities - OSL
- Australian Manufacturing Facility Achieves ISO 13485
Later from OncoSil Medical
- Notice of AGM date
- OncoSil Clinical Data to be Presented at EANM 2026
- PALACROS Officially Launched in Amsterdam
- Notice of Annual General Meeting/Proxy Form
- Updated OSPREY Overall Survival Data Presented at EAMN
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical